stockrow
Friday 6 November 2026
Export TEM’s income statement to Excel — free account
Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.
- Revenue
- +23.1%
- EPS
- +82.2%
- Free cash flow
- +95.7%
- Total debt
- +8.44%
Quarter to September 2026, against a year earlier
76.26
5.83
+8.28%
Follow TEM
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 5 | 4 |
+8 more TTM periods Free account |
| (37.55%) | (67.44%) | (81.58%) | (89.48%) | ||
| (8.00%) | (12.75%) | (16.47%) | (15.31%) | ||
ROIC |
(14.36%) | (17.87%) | (16.63%) | (16.20%) | |
Return on Tangible Assets |
(23.79%) | (25.74%) | (36.74%) | (27.72%) | |
Average Days of Receivables |
92.07 | 91.99 | 82.57 | 89.31 | |
Free Cash Flow per Share |
(0.83) | (1.52) | (1.23) | (1.41) | |
Free Cash Flow |
(150.63) | (272.97) | (219.70) | (245.35) | |
Capital Expenditures |
(42.25) | (35.54) | (33.96) | (27.26) | |
| Other line items | |||||
Cash ROIC |
(6.05%) | (10.41%) | (9.60%) | (9.87%) | |
Accounts Receivable Turnover |
4.54 | 4.57 | 4.78 | 5.46 | |
Accounts Payable Turnover |
8.25 | 6.74 | 7.70 | 6.98 | |
Inventory Turnover |
9.86 | 10.20 | 9.76 | 10.52 | |
Average Days of Payables |
47.98 | 52.23 | 29.98 | 63.15 | |
Days of Inventory on Hand |
36.59 | 37.87 | 37.88 | 39.84 | |
Tax Rate |
(0.03) | (0.02) | (0.02) | (0.18) | |
Research and Development Expense of Revenue |
24.72% | 25.45% | 25.21% | 25.09% | |
Selling, General and Administrative Expense of Revenue |
58.22% | 58.30% | 57.89% | 57.54% | |
Share Based Compensation of Revenue |
13.27% | 13.00% | 11.32% | 9.81% | |
Interest Coverage |
(5.98) | (5.12) | (4.04) | (3.60) | |
Operating CF/Net income |
0.57 | 0.93 | 0.61 | 0.89 | |
Depreciation/Fixed assets |
1.18 | 1.26 | 1.28 | 1.20 | |
Capex/Depreciation |
(0.38) | (0.32) | (0.30) | (0.26) | |
Revenue per Share |
8.32 | 7.96 | 7.63 | 7.30 | |
Operating CF per Share |
(0.60) | (1.32) | (1.04) | (1.25) | |
Capex per Share |
(0.23) | (0.20) | (0.19) | (0.16) | |
Capex to Sales |
0.03 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026